DEXCOM, INC. (DXCM) Return on equity 2016–2025
DEXCOM, INC. (DXCM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
30.5%FY2025 · since FY2016: -23.1% → 30.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 30.5% | +3.1 pp |
| FY2024 | 27.4% | +1.2 pp |
| FY2023 | 26.2% | +10.2 pp |
| FY2022 | 16.0% | +5.4 pp |
| FY2021 | 10.6% | -24.8 pp |
| FY2020 | 35.4% | +24.0 pp |
| FY2019 | 11.5% | +30.6 pp |
| FY2018 | -19.2% | -7.2 pp |
| FY2017 | -12.0% | +11.1 pp |
| FY2016 | -23.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More DXCM financial trends
DXCM RevenueDXCM Net incomeDXCM Net marginDXCM Gross profitDXCM Gross marginDXCM Operating incomeDXCM Operating marginDXCM Operating cash flowDXCM Free cash flowDXCM Capital expendituresDXCM Stock buybacksDXCM Dividends paidDXCM Total assetsDXCM Total liabilitiesDXCM Shareholders’ equityDXCM overview →